| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
1,097 |
757 |
$1.58M |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
694 |
519 |
$1.29M |
| J0491 |
Injection, anifrolumab-fnia, 1 mg |
255 |
229 |
$912K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,886 |
1,673 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,586 |
1,506 |
$125K |
| 95912 |
|
446 |
406 |
$111K |
| 95886 |
|
518 |
468 |
$86K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,070 |
1,013 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
336 |
319 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
262 |
260 |
$27K |
| 95911 |
|
37 |
31 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
14 |
$614.77 |
| 96401 |
|
19 |
13 |
$489.08 |